Related Experiment Videos
[Compressive sclerotherapy monitored by ultrasound]
P Labas1, B Ohrádka, V Stvrtinová
1I. chirurgická klinika LF UKo, Bratislava, Slovenská republika.
Rozhledy V Chirurgii : Mesicnik Ceskoslovenske Chirurgicke Spolecnosti
|November 26, 1998
Summary
Echosclerotherapy offers a major advance in treating chronic venous insufficiency by enabling targeted treatment and preventing complications. Ultrasound-guided sclerotherapy effectively closes key reflux sites, improving patient outcomes.
Area of Science:
- Vascular Surgery
- Interventional Radiology
Background:
- Chronic venous insufficiency (CVI) presents significant clinical challenges.
- Pathological venous reflux is a primary driver of CVI symptoms.
Purpose of the Study:
- To evaluate the efficacy of echosclerotherapy and sonographic control in CVI treatment.
- To assess the prevention of complications associated with sclerotherapy.
Main Methods:
- Functional venous examination to identify reflux sites.
- Ultrasound-guided sclerotherapy for precise administration of sclerosants.
- Compressive sclerotherapy with ultrasound monitoring.
Main Results:
- Echosclerotherapy facilitates targeted administration of active substances.
- Ultrasound guidance prevents sclerosant injection into healthy veins.
- Achieved up to 90% occlusion of major reflux sites (saphenofemoral, saphenopopliteal orifices).
Conclusions:
- Echosclerotherapy represents a significant advancement in CVI management.
- Sonographic control enhances treatment safety and efficacy.
- Effective closure of reflux sites leads to improved clinical outcomes.